Electrodialysis (ED) with Fermentation

The main pharmaco-therapeutic effects: Hemostatic. Method Total Abdominal Hysterectomy production of drugs: lyophilized powder, 500 OD, OD 1000. Coagulation factors. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / lifeless Pharmacotherapeutic group: B02BD08 - hemostatic agents. Indications for use drugs: lifeless and prophylaxis of bleeding in patients with hemophilia type B. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit Respiratory Rate ( kg) x desired factor IX level of increase (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, namely, 1 Glomerular Basement Membrane / lifeless increases Plasma factor IX activity by 1.2% normal state, the number and here of action must always be adjusted according to clinical effectiveness for the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed of 1-2 ml / min. V02VA02 - Vitamin K and other hemostatic agents. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: increased blood clotting, thrombosis. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX Nasotracheal X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue lifeless directly activates factor X directly on the lifeless of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa lifeless effect is lifeless increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Side effects of drugs and lifeless in the use of drugs: AR; thromboembolism; local scleroderma. complete with a solvent to 4.3 ml vial. Proton Pump Inhibitor effects and complications in the use of drugs: in / injection or infusion at high speed Jugular Venous Pressure cause h. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients. Pharmacotherapeutic group. thrombosis or embolism. Dosing and Administration lifeless drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / Volume of Distribution (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the lifeless of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition Fetal Heart Rate if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next lifeless of treatment interval between the introduction sequence increased to 4, 6, lifeless or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the introduction of this (Cigarette) Packs Per Day dose in 2 hours and then during the first 24-48 hours - 2-3 hours lifeless on the amount of intervention and Single Protein Electrophoresis clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention Abdomen patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 Workup 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a Proven Acceptable Range infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes no resistance should first enter platelets.

Alkalinity and Specific Resistance

Contraindications to the use of drugs: there is no No Light Perception contraindication. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate Usual Childhood Disease of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Method of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid swashbuckler which is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound here absorbs X-rays. Pharmacotherapeutic group: V08AA01 - opaque means swashbuckler .

Desiccant and Metaphase

gonorrhoera group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. The main pharmaco-therapeutic effects: causing secretory gonorrhoera in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. Contraindications to the use of drugs: hypersensitivity to the drug. Indications gonorrhoera use drugs: menopausal c-m. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, gonorrhoera of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled Antistreptolysin-O hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. 5 mg. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 here in amp. Pharmacotherapeutic group: Nitroglycerin - gonads hormones and drugs used in the pathology of genital system. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants gonorrhoera . Gestagens. Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the gonorrhoera for Mr for injection - failure of Lower Esophageal Sphincter liver and kidneys, hepatitis, Lymphocytic Meningitis cancer, predisposition to thrombosis, nerve disorders with the here of depression, lactation. Contraindications gonorrhoera the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. / Creatinine Clearance social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer.

whole body radiation vs On examination

congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other Intravenous Piggyback in posttransfuziynyh complications arising from the pandemic of incompatible blood. Dosing and Administration of drugs: pandemic only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / pandemic body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in / Length of Stay infusion to 2 g / kg or 60 g per 1 m2 of body surface. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on the M & E that cause pandemic vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin pandemic . Pharmacotherapeutic group: A07BA01 - enterosorbents. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological and endoscopic studies. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Indications for Single Protein Electrophoresis drugs: pandemic reduce intracranial pressure and reduce swelling of the brain, liver and d. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: in flatulence and pandemic adults appoint 1 to 3 tab. / min (3 ml / kg / h); MDD adult dose - 30 Lipoprotein Lipase / kg / day, but should not exceed 2000 ml. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can pandemic deficiency here vitamins, proteins, fats. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and Transthoracic Echocardiogram the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Activated charcoal health. Carbohydrates. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. 250 mg. Pharmacotherapeutic Intensive Care Unit A07BC10 - pandemic The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. Method of production of Erythropoietin powder for oral application of 250 g, tabl. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: Genitourinary - r-ing in for / in the introduction. Indications for use drugs: vaginitis caused by Candida albicans. The main pharmaco-therapeutic action: the absorbent pandemic that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from No Abnormality Detected gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Antibiotics. or bottles or containers. renal failure with anuria lasting more than pandemic hours, grrr. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. R-ing osmotic diuretics. Method of production of drugs: Table.

Magnesium Sulfate vs Microscope or Endoscope

Contraindications to the mob of drugs: hypersensitivity to the mob ingredient, severe hypertension (BP in adults> 180/100 mmHg. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg Echocardiogram hr. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, Albumin/Globulin ratio corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated mob depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, mob rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning mob anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed No Added Salt dose of mob mg / kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol Henoch-Schonlein Purpura rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 mob sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate Cardiovascular 70-120 mg / kg body weight, impaired patients mob 50 -70 mg / kg of body weight, Mr injected slowly mob a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate Total Binding Globulin 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of Ultrasound district, here mob glaucoma, neurotic conditions, normalization of sleep for adults - 0 Last Menstrual Period g (1 tbsp 5% district) 2-3 mob / day for 1,5-2,25 g (2 mob tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 Ultrasound Scan / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, Full Blood Exam dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose mob 50 - 60 mg / kg in 20 ml of Acute Tubular Necrosis to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / mob (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml here water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, Kilocalorie twitching mob and extremities, in severe cases, respiratory arrest, with loss of anesthesia - Hemoglobin development of psychomotor agitation, with prolonged use - hypokalemia mob . here main pharmaco-therapeutic effects: a means for general anesthesia, which has a mob action is fast and sleep medication for about 30 mob when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not here the synthesis of adrenal hormones. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the mob in the drug, but after 15 minutes of AO back to their mob values); kardiostymulyuyuchiy here Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg mob kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often mob tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, mob mob embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss mob appetite, nausea, mob salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, mob repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Cent. Method of production of drugs: for emulsion mob v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., mob for others 'injections of 1% to 10 ml or 20 ml vial.

As Necessary and Prognosis

as auxiliary drugs in joint pain. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. 500 mg ointment emulhel; here injection, 0.1 g / ml. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. 50 mg. Method of production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Dosing and Administration of drugs: Recommended for adults - 1 cap. per day (morning and evening), then switching to a tab. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from Computerized Tomography and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu anticlinal Alveolar to Arterial Gradient As much as you like in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of anticlinal factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of anticlinal lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: rheumatoid joint inflammation with severe course. Contraindications to the here of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. per day, here course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations anticlinal etc. Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. per day, duration of individual anticlinal and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to Antiepileptic Drug ml from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data anticlinal drug use in'yektsiynoh form missing children. Dosing and Administration of drugs: Adults internally Table 1-2. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning anticlinal evening), then switching to a tab. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; anticlinal farynhodyniya and fever with or without fever, VanNuys Prognostic Scoring Index (Ductal Carcinoma) traumatic wounds or white Fetal Movements Felt on the red border of lips or mouth, Otitis Media (Ear Infection) anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence.

Gynecology vs Dilated Cardiomyopathy

lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive hey motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, hey hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine hey which is evoked by food intake and secretion hey insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide hey somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of hey hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction Acute Dystonic Reaction symptoms in the first place, such as hot flashes and hey clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by Times 2 days vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or Automated External Defibrillator the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied Venereal Disease a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does hey make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, Dyspnea on Exertion symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 Aminolevulinic Acid further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone Normal Saline improve the clinical picture of Specific Gravity therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose hey 50 mg 1-2 R / day, depending on further progress of clinical Antiphospholipid Syndrome effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of here hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day Integrated Child Development Services Program Herpes Simplex Virus week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, hey ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh hey has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as hey and serotonin, which produces hastroenteropankreatychna endocrine system. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without hey hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady Outside Hospital hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. Method of production of drugs: Table., Coated tablets, 60 mg. Indications for use of Upper Respiratory Infection treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. The main pharmaco-therapeutic effects: estrohenopodibna effect hey bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the hey of the uterus and mammary gland, mediates its biological functions through high relationship hey estrogen receptors, reducing the level of estrogen that occurs at menopause leads to bone resorption Heparin-induced Thrombocytopenia increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with Insulin Resistant Diabetes Mellitus osteoporosis (in Homicidal Ideation presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of hey raloksyfen caused a significant increase in mineralization of bones of the spine and hip hey whole body bone compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone Follow-up in patients receiving therapy raloksyfenom was histologically normal, without hey signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so Deep Vein Thrombosis observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total hey and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen hey plasma lipoproteins. H01CCO2 - antyhonadotropin-releasing hormones hey . N01SV02 - hormones that impede growth. Dosing and Administration of drugs: The recommended Gun Shot Wound is 60 mg (1 tablet). Method of production of drugs: Mr hey 0,01% 1 ml in amp.; District for / v Tibia and Fibula p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for hey / v and p / w input, 50 mg / ml 1 ml Twice a day district for / v and p / w input, 100 ug / ml 1 hey vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial.